Insider filing · MLTX
Mark N Lampert
Director
profile →
MoonLake Immunotherapeutics
MLTX · Healthcare · 18 filings in 24 months
ticker →
Mark N Lampert sold $63.0M of MoonLake Immunotherapeutics (MLTX)
Executed Mar 31, disclosed Apr 2, 2 days later.
Value, as filed
$63.0M
3,750,000 sh across 3 lots
Executed
Mar 31
the trade date, as filed
Disclosed
Apr 2
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MLMark N Lampert (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in MoonLake Immunotherapeutics (MLTX). The largest single filing was $63.0M of MLTX (3,750,000 sh across 3 lots, as filed), executed Mar 31.
The name
MLTXHealthcare · MoonLake Immunotherapeutics, a clinical-stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseas…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→